PF_05221304



NAME OF DRUG : PF_05221304

ALSO KNOWN AS : PF_05221304

LABORATORY : PFITZER

STATUS AND ADVANCEMENT

Type of drug : Acetyl CoA-Carboxylase (ACC) Inhibitor

Clinical trials advancement : Recruiting Phase 2a

The drug got the Fast Track Status granted by the FDA

Estimated time to market : 99 months.

LABORATORY ABSTRACT ON THE DRUG

NOT PROVIDED

RECENT NEWS ON PF_05221304

SOME PUBLICATIONS RELATED WITH PF_05221304

SOME NASHBIOTECHS POINTS OF VIEW RELATED WITH PF_05221304


WWW.NASHBIOTECHS.COM  -  Copyright G DIVRY 2015-2016  - Contact and TERMS OF USE